Avicanna closes Medical Cannabis by Shopper’s acquisition; launches MyMedi.ca

Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) said it has closed its previously-announced acquisition of the Medical Cannabis by Shopper’s Business from Shoppers Drug Mart and revealed the launch of an all-new medical cannabis care platform, MyMedi.ca, nationwide across Canada.

The biopharmaceutical firm said its medical cannabis care platform has features that include a diverse medical cannabis marketplace featuring about 200 unique products supplied by a network of 35 brands from various leading Canadian licensed producers, as well as pharmacist-led fully bilingual (English and French) patient care service programs including pharmacovigilance, compassionate pricing, and insurance adjudication in compliance with standards established by private and public payers.

“We are pleased to have closed the acquisition of the Business from Shoppers Drug Mart and recognize this as a transformational milestone in the life of our company,” Avicanna CEO Aras Azadian said in a statement.

“We are motivated to meet the needs of our new patients through MyMedi.ca and welcome the thousands of patients that have transitioned over from the Medical Cannabis by Shoppers platform,” he added.

MyMedi.ca also provides patient education programs and informational resources, including harm reduction strategies and risk mitigation, in addition to medical education, training, and resources available to healthcare practitioners, hospitals, clinics, and institutions, along with potential collaboration opportunities, through the company’s Medical Affairs department, Avicanna added.

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments.


Primary Sponsors

Get Connected

Karma Koala Podcast

Top Marijuana Blog